Cannabis
The First Medical Cannabis Agricultural Cooperative in Argentina
While at national level the Law of Productive Cannabis is being debated, which will promote the constitution of Cooperatives that operate within the cannabis value chain, La Entrerriana, can already begin to operate within the provincial law, being an example for future cases. The cooperative will be authorized and will be dedicated to the production of flowers and phytopreparations for medicinal purposes.
Members of a new cooperative presented, to the Concordia delegation of INAE, the forms to register their entity. The registration of the Agricultural Cannabis Cooperative “La Entrerriana” was formalized at the Directorate of Cooperatives and Mutuals.
From the cooperative, they considered that “it constitutes a historical fact at the national and provincial level since it will be the first Cannabis Cooperative of the country”, they indicated and added that “the recently sanctioned Law N° 10.894, of Access to the Cannabis of the Province of Entre Ríos, is materialized by means of this action, which puts again to the province in the vanguard of the thematic one.”
read more on the subject and find the most important cannabis news in the world with the Hemp.im mobile app.
Entre Rios a pioneer province in the medical cannabis market
Piero Liebman said that “it will be installed in the province and it is a very important fact, due to the place that Entre Ríos is occupying in the cannabis market”.
While at national level the Law of Productive Cannabis is being debated, which will promote the constitution of Cooperatives that operate within the cannabis value chain, “the Cooperativa Cannábica La Entrerriana, can already begin to operate within the provincial law, being an example for future cases,” they pointed out.
Medicinal production
The cooperative will be authorized and will be dedicated to the production “of flowers and phytopreparations for medicinal purposes, being able to commercialize with pharmacies, social security, municipalities, and the Provincial State, in order to guarantee access to health for the people of Entre Ríos, opening the door to this incipient and great market, which will undoubtedly be extremely fruitful for our country,” highlighted from the cooperative.
“All the products derived from cannabis that are produced must be destined for medicinal and therapeutic use. We always talk about guaranteeing access to health and not any other type of access,” Liebman explained and added that “the production fields will be in Entre Ríos, as the law states, and we chose to settle in the city of Concordia to start working.”
Medical cannabis will generate income and jobs
“We believe that this is a kick-off to generate great income for the province, for the municipality, and also, as an important source of genuine employment”, said Liebman, who together with Javier Orduna, are the lawyers in charge of the legal procedures of the cooperative.
The lawyer said that “at the moment, we are 10 cooperative members with different functions, but we will have to incorporate cultivation technicians, laboratory technicians, extractors, caretakers of the crops, etc.”.
Cannabis projects
“We are part of the committee that drafted Law No. 10,894 on Access to Cannabis in the Province of Entre Ríos and we have been working hard in the province to advance different projects related to cannabis because we believe it will be a great source of income and work for Entre Ríos”, said the lawyer and added that “now we must wait for the approval as a cooperative at the INAE of Concordia and the INAE at the national level. Only after that, we will be able to operate in the market.”
__
(Featured image by Pexels via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in ELENTRERIOS, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech1 week ago
Bayer Bets on Barcelona with a New R&D Area in Health
-
Crypto2 weeks ago
SEC Blocks Solana ETFs Ahead of Leadership Change
-
Impact Investing5 days ago
SBTi Approves DKV Mobility’s Decarbonization Targets
-
Fintech2 weeks ago
Pennylane and Defacto Strengthen Alliance to Facilitate Instant Payments for SMEs